Navigation Links
DoseCue(TM) Presents Positive Study Results at BioTech 2009
Date:11/16/2009

PHILADELPHIA, Nov. 16 /PRNewswire/ -- DoseCue, LLC announced this week that medication containers equipped with their automatic dose-time reminder devices significantly increase compliance, or adherence, according to results from a recent study.

The data, which were presented at BioTech 2009 in Philadelphia, showed that DoseCue electronic devices significantly improved patient compliance with oral-dose medications by 9.1%, without adding steps or changing the patient's dose-taking routine. In addition, overall compliance averaged 97.1% in the Study Group in Phase 2.

"This represents an important 'first'," stated DoseCue CEO, Mark Burrows. "The DoseCue trial is the first of its kind to achieve a statistically significant improvement in compliance using this one-of-a-kind, patented technology," he added, noting 95% Confidence Interval.

DoseCue's patented technology is integrated directly into manufacturers' current containers during filling and issues automatic reminder cues to patients when a medication needs to be dosed and signals when the dose has been taken. Electronics are integrated into the medication container itself, not the closure, to avoid mix-up and help differentiate the product.

The DoseCue study was conducted at a retail pharmacy to determine if patient compliance improved when oral-dose medications were dispensed in a DoseCue-equipped container. Thirty-five (35) patients were enrolled and randomized into either a Control or Study Group. All patients used an inactive container for Month 1 (Phase 1) which, unknown to participants, automatically logged date and time of open/close events, after which half were crossed-over to a container which also cued at dose time (Study Group). Remaining patients continued use of the inactive container (Control Group). Twenty-four (24) patients completed the study.

"We know the costs of non-compliance are high," said Burrows. "With DoseCue, there's no guesswork and compliance rates improve, resulting in better disease management, increased sales, and lower costs to the healthcare system."

DoseCue, LLC is a medication compliance company that integrates electronic dose-time reminder cues into manufacturers' existing factory-filled containers. These containers are clinically proven to increase compliance and remove the burden on patients to remember to take their oral-dose medication as prescribed by their physician.

www.dosecue.com

SOURCE DoseCue, LLC


'/>"/>
SOURCE DoseCue, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Frontiers in Optics presents scientific advancements
2. New book presents successful strategies for probing genetic variation
3. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
4. New book presents methods to poke and prod individual molecules
5. Internationally recognized experts presents a complete overview on hydroecology and ecohydrology
6. Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings
7. ICS presents prestigious Digby McLaren Medal to Cincinnatis Carl Brett
8. Penn presents inaugural symposium on applied mathematics and computational science
9. Soil Science Society of America presents 2008 fellows
10. Soil Science Society of America presents awards in Houston
11. Arbor Vita presents new data on cancer diagnostic at EUrogin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in ... biometrics market" The mobile biometrics market is expected to ... 49.33 billion by 2022, at a CAGR of 29.3% ... factors such as the growing demand for smart devices, ... transactions. "Software component is expected to grow ...
(Date:12/8/2016)... Dec. 8, 2016  Singulex, Inc., the leader in ... entered into a license and supply agreement with Thermo ... agreement provides Singulex access to Thermo Scientific BRAHMS PCT ... is used to diagnose systemic bacterial infection and ... to aid in assessing the risk of critically ...
(Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... January 20, 2017 Stock-Callers.com explores ... have influenced the most recent performances of select equities. ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... Grand View Research, global Biotech market size is expected to reach $604.40 ...
(Date:1/20/2017)... 2017 http://www.Financialbuzz.com - ... leading causes of death worldwide. There were 8.2 million ... cancer related deaths increased gradually over time, the death ... of various cancers continues to drive demand of biological ... Global Market Insights, Inc. cancer biological therapy market size was ...
(Date:1/19/2017)... 2017 Research and Markets has announced the ... Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... market is projected to reach $15,737 million by 2022 from $6,521 ... 2022. Omic technologies segment accounted for more than ...
(Date:1/19/2017)... and HOUSTON , Jan. 19, ... today announced the formation of its Medical/Clinical Advisory ... and industry veterans who enhance the range and ... accelerates development of its novel prenatal diagnostic tests.  ... clinical and strategic guidance for the company,s product ...
Breaking Biology Technology: